Physician profile
Elliot Davidoff
NPI 1760485734
$2,432.87
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,186 · 2020: $191 · 2021: $38.28 · 2022: $303 · 2023: $347 · 2024: $366.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $714.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $713.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $518.75 | 2019-2024 | Eylea Hd, Eylea |
| Allergan, INC. | $396.86 | 2019 | |
| Alcon Vision LLC | $300.21 | 2019-2024 | Rocklatan, Hydrus Microstent, Precision 1 |
| Aerie Pharmaceuticals, INC. | $189.25 | 2019-2020 | |
| Abbvie INC. | $184.48 | 2022-2024 | Lumigan, Alphagan P |
| Novartis Pharmaceuticals Corporation | $164.36 | 2019-2023 | |
| New World Medical,INC. | $145.59 | 2023-2024 | Clearpath, Streamline, Kahook Dual Blade |
| Spark Therapeutics, INC. | $120.97 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $99.99 | 2019 | |
| Mallinckrodt Hospital Products INC. | $64.94 | 2022-2023 | Acthar |
| Tarsus Pharmaceuticals, INC. | $56.31 | 2024 | Xdemvy |
| Johnson & Johnson Surgical Vision, INC. | $31.25 | 2022-2024 | Tecnis Iol |
| Rayner Intraocular Lenses Limited | $29.72 | 2022-2023 | Rayone Aspheric, Rayone Spheric, Rayone Emv |
| Sun Pharmaceutical Industries INC. | $29.60 | 2020 | |
| Apellis Pharmaceuticals, INC. | $28.58 | 2022-2023 | Syfovre |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $23.06 | 2023 | |
| Bausch & Lomb Americas INC. | $18.81 | 2024 | Miebo |
| Omeros Corporation | $16.09 | 2019 | |
| Oyster Point Pharma, INC. | $14.05 | 2023 | Tyrvaya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elliot Davidoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.